UAB researchers are studying two breathing tubes that EMS crews use to treat cardiac arrest patients, including this one, the King laryngeal tube.
Investigators at the University of Alabama at Birmingham want to determine whether using the King LT produces better results than existing endotracheal tubes in cases of out-of-hospital cardiac arrest.
UAB’s Alabama Resuscitation Center is spearheading the national trial involving paramedics in five U.S. metropolitan areas.
“Out-of-hospital cardiac arrest is a major public health problem in this country with some 300,000 cases per year,” said Henry Wang, MD, professor and vice chair for Research in the UAB Department of Emergency Medicine. “Only about 10% survive, and airway management during cardiac arrest is an extremely important aspect of treatment.”
Wang is the national principal investigator for the Pragmatic Airway Resuscitation Trial — or PART — which will examine the endotracheal tube’s performance against the King laryngeal tube to see whether either produces higher 72-hour survival rates in adults with cardiac arrest treated by EMS practitioners.
“While both are commonly used by paramedics, we do not have a consensus as to which is a better choice for use in adult cardiac arrest,” Wang said. “The endotracheal tube can be difficult and time-consuming to insert properly. The King LT is just one of several newer airway devices that show great promise but need to be studied.”
PART will be conducted in Birmingham, Dallas, Milwaukee, Pittsburgh and Portland. Locally, the Bessemer Fire Department is the first EMS agency in the country to take part.
Research released earlier this year found hospital treatment for commonly-prescribed opioid painkillers increased 137 percent in Missouri over the last 10 years.
Without an extension, the 85 paramedics with North Collier fire would no longer be able to practice the full gamut of medic procedures starting Jan. 1.
New Ebola cases in Liberia raise fears that neighboring Sierra Leone, recently declared Ebola free, may suffer similar setbacks in eradicating the disease.
Voice your opinion!